Hepatolithiasis and intrahepatic cholangiocarcinoma: A review

Table 3 Clinical characteristics of subsequent cholangiocarcinoma patients[33]

Case	Sex/age	Location of stone	Treatment method	Residual stone	Time of CC (mo)	Location of CC	Stage
1	M/65	Lt	ERCP	Yes	14	Lt	IVA
2	M/69	Lt	PTCSL	Yes	15	Lt	III
3	M/72	Lt	PTCSL	Yes	17	Lt	IVA
4	M/66	Lt	ERCP	Yes	21	Lt	III
5	M/51	Lt	PTCSL	Yes	13	Lt	IVA
6	M/63	Lt	PTCSL	No	53	Lt	IVA
7	F/71	Rt	ERCP	Yes	79	Both	III
8	F/54	Both	PTCSL	Yes	10	Lt	IVA
9	F/56	Rt	PTCSL	No	111	Rt	IVA
10	F/65	Both	PTCSL	Yes	72	Lt	IVA
11	M/60	Both	Lt. hemi-hepatectomy	Yes	102	Rt	III
12	F/67	Both	Lt. lobectomy	Yes	55	Rt	IVA
13	F/51	Lt	Lt. hemi- hepatectomy	No	109	Lt	II
14	M/52	Both	Lt. lobectomy	Yes	28	Rt	IVA
151	F/47	Lt	Lt. hemi-hepatectomy	No	14	Caudate	III
16	F/56	Both	Lt. lobectomy	Yes	81	Rt	IVB

¹Described in Figure 3. M: Male; F: Female; CC: Cholangiocarcinoma; Lt: Left; Rt: Right; ERCP: Endoscopic cholangiopancreatography; PTCSL: Percutaneous transhepatic choledochoscopic lithotomy.